These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats. Mally A, Pepe G, Ravoori S, Fiore M, Gupta RC, Dekant W, Mosesso P. Chem Res Toxicol; 2005 Aug; 18(8):1253-61. PubMed ID: 16097798 [Abstract] [Full Text] [Related]
26. In situ detection of acetylaminofluorene-DNA adducts in human cells using monoclonal antibodies. Iwamoto TA, Kobayashi N, Imoto K, Yamamoto A, Nakamura Y, Yamauchi Y, Okumura H, Tanaka A, Hanaoka F, Shibutani S, Miyagawa S, Mori T. DNA Repair (Amst); 2004 Nov 02; 3(11):1475-82. PubMed ID: 15380103 [Abstract] [Full Text] [Related]
29. Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases. Izzotti A, D'Agostini F, Bagnasco M, Scatolini L, Rovida A, Balansky RM, Cesarone CF, De Flora S. Cancer Res; 1994 Apr 01; 54(7 Suppl):1994s-1998s. PubMed ID: 8137327 [Abstract] [Full Text] [Related]
30. Alternative conformations of DNA modified by N-2-acetylaminofluorene. Grunberger D, Santella RM. J Supramol Struct Cell Biochem; 1981 Apr 01; 17(3):231-44. PubMed ID: 7328672 [Abstract] [Full Text] [Related]
31. Temporal patterns of DNA adduct formation and glutathione S-transferase activity in the testes of rats fed aflatoxin B1: a comparison with patterns in the liver. Sotomayor RE, Sahu S, Washington M, Hinton DM, Chou M. Environ Mol Mutagen; 1999 Apr 01; 33(4):293-302. PubMed ID: 10398377 [Abstract] [Full Text] [Related]
34. Immunohistochemical localization of DNA adducts in rat liver tissue and phenotypically altered foci during oral administration of 2-acetylaminofluorene. Huitfeldt HS, Spangler EF, Hunt JM, Poirier MC. Carcinogenesis; 1986 Jan 01; 7(1):123-9. PubMed ID: 3510747 [Abstract] [Full Text] [Related]
35. Monitoring the exposure of rats to 2-acetylaminofluorene by the estimation of mutagenic activity in excreta, sister-chromatid exchanges in peripheral blood cells and DNA adducts in peripheral blood, liver and spleen. Willems MI, de Raat WK, Baan RA, Wilmer JW, Lansbergen MJ, Lohman PH. Mutat Res; 1987 Feb 01; 176(2):211-23. PubMed ID: 3543665 [Abstract] [Full Text] [Related]
36. Formation and persistence of DNA adducts during and after a long-term administration of 2-nitrofluorene. Cui XS, Eriksson LC, Möller L. Mutat Res; 1999 Jun 07; 442(1):9-18. PubMed ID: 10366768 [Abstract] [Full Text] [Related]
37. Solution structure of the aminofluorene-intercalated conformer of the syn [AF]-C8-dG adduct opposite a--2 deletion site in the NarI hot spot sequence context. Mao B, Gorin A, Gu Z, Hingerty BE, Broyde S, Patel DJ. Biochemistry; 1997 Nov 25; 36(47):14479-90. PubMed ID: 9398167 [Abstract] [Full Text] [Related]
38. DNA adduct formation and removal in hepatic chromatin fractions from rats chronically fed 2-acetylaminofluorene. Poirier MC, Fullerton NF, Patterson ED, Beland FA. Carcinogenesis; 1990 Aug 25; 11(8):1343-7. PubMed ID: 2387020 [Abstract] [Full Text] [Related]
39. Intestinal microflora enhances formation of DNA adducts following administration of 2-NF and 2-AAF. Möller L, Zeisig M, Midtvedt T, Gustafsson JA. Carcinogenesis; 1994 May 25; 15(5):857-61. PubMed ID: 8200087 [Abstract] [Full Text] [Related]
40. Comparison of hprt and lacI mutant frequency with DNA adduct formation in N-hydroxy-2-acetylaminofluorene-treated Big Blue rats. Chen T, Mittelstaedt RA, Aidoo A, Hamilton LP, Beland FA, Casciano DA, Heflich RH. Environ Mol Mutagen; 2001 May 25; 37(3):195-202. PubMed ID: 11317337 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]